Andrew Sundberg

Andrew joined PreludeDx as the Vice President of Global Sales in November 2016, bringing a breadth of business experience in the molecular genomics and clinical diagnostics industries to the company. Andrew came to PreludeDx from Agendia, Inc., where he held the position of Senior Director of National Accounts, responsible for the collaboration and sales integration for all of Agendia’s genomic profiling cancer assays. Andrew joined Agendia in February 2008 as the Director of Sales to develop, and launch the U.S. strategic plan.

Prior to his tenure with Agendia, Andrew was with Genomic Health, Inc. where he leveraged his medical start-up and business expertise to launch OncotypeDx to the U.S. Market. Previous to Genomic Health, Mr. Sundberg was the National Product Development Manager and Western U.S. Sales Manager with IMPATH, Inc., a diagnostic laboratory services company.

Andrew received a Bachelor Of Science degree from the Rochester Institute of Technology, in Rochester, NY.